The complete scientifc program has not been published yet. We will update any information asap.

Learning Objectives
• Summarize current concepts about molecular mechanisms, laser and surgical treatments of diabetic retinopathy, and new concepts on the horizon
• Acquire updates on current clinical trials of new pharmacotherapies of diabetic retinopathy and analyze the challenges ahead
• Identify new targets and formulate research strategies to develop new therapies and clinical trials
 
Keynote Speaker:

Napoleone Ferrara, MD, USA

Confirmed Speakers:

Gary Abrams, MD, USA
Jay Ambati, MD, USA
David Antonetti, PhD, USA
Manuela Bartoli, PhD
Julia Busik, PhD, USA
Subrata Chakrabarti, MBBS, PhD, Canada
Diana Do, MD, USA
Edward Feener, PhD, USA
Tom Gardner, MD, USA
Michael Ip, MD, USA
George King, MD, USA
Jay Ma, PhD, USA
Susanne Mohr, PhD, USA
Quan Nguyen, MD, USA
Daniel Palanker, PhD, USA
Susanna Park, MD, USA
John Penn, PhD, USA
Sayon Roy, PhD, USA
Lucia Sobrin, MD, USA
Akrit Sodhi, MD, USA
Jena Steinle, PhD, USA
Alan Stitt, PhD, Ireland
Jennifer Sun, MD, USA

Target Audience
The educational design of this activity addresses the needs of basic and clinician scientists involved in the research and/or treatment of patients with  diabetic retinopathy.
 
Venue Address:
El Dorado Hotel
309  W San Francisco Street
Santa Fe, NM 87501
(505 988-4455
 
Organizers:
Arup Das, MD, PhD, Univ. of New Mexico, Albuquerque, USA
Renu Kowluru, PhD, Wayne State University, Detroit, USA
Maria Grant, MD, Univ. of Alabama, Birmingham, USA
Lloyd Aiello, MD, PhD, Harvard University, Boston, USA
Ashwath Jayagopal, PhD, Kodiak Sciences, Palo Alto, USA